Literature DB >> 8213206

Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patients.

H Ohsawa1, T Kishimoto, N Shimayoshi, K Matsumura, K Tahara, K Kitera, N Higashiura, Y Noriyama, H Matsumoto, M Hirai.   

Abstract

Plasma levels of arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) were measured in 15 patients with schizophrenic or schizoaffective disorders and 15 healthy volunteers during oral water loading at 20 ml/kg. In the patient group, plasma AVP was secreted even when plasma osmolality was below 270 mosmol/kg, although the sensitivity of AVP secretion response to osmolality was lower than in the controls. The ANP level was higher in the group of patients than in the controls. There was a negative correlation between plasma ANP and osmolality in the patients. We speculate that the volume expansion caused by inappropriate AVP secretion stimulated plasma ANP release and that the natriuresis resulting from the elevated plasma ANP level might contribute to hyponatremia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213206     DOI: 10.1111/j.1600-0447.1993.tb03426.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  8 in total

1.  Modulation of parvalbumin interneuron number by developmentally transient neocortical vasopressin receptor 1a (V1aR).

Authors:  E A D Hammock; P Levitt
Journal:  Neuroscience       Date:  2012-07-20       Impact factor: 3.590

Review 2.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 3.  Brain circuit dysfunction in a distinct subset of chronic psychotic patients.

Authors:  Morris B Goldman
Journal:  Schizophr Res       Date:  2014-07-01       Impact factor: 4.939

Review 4.  A systematic review of the ability of urine concentration to distinguish antipsychotic- from psychosis-induced hyponatremia.

Authors:  Wanlop Atsariyasing; Morris B Goldman
Journal:  Psychiatry Res       Date:  2014-03-29       Impact factor: 3.222

5.  Vasopressin eliminates the expression of familiar odor bias in neonatal female mice through V1aR.

Authors:  Elizabeth A D Hammock; Caitlin S Law; Pat Levitt
Journal:  Horm Behav       Date:  2012-12-21       Impact factor: 3.587

6.  Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment - need for more short- and long-term studies.

Authors:  Owais Gul; Saqib Gul; Abdul Aziz Godil
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-05       Impact factor: 2.570

Review 7.  Multiple Aspects of Inappropriate Action of Renin-Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases.

Authors:  Ewa Szczepanska-Sadowska; Agnieszka Wsol; Agnieszka Cudnoch-Jedrzejewska; Katarzyna Czarzasta; Tymoteusz Żera
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241

8.  Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia.

Authors:  Derya Guzel; Ahmet Bulent Yazici; Tugba Mutu Pek; Songul Doganay; Alime Burcin Saykan Simsek; Kadir Saglam; Caglar Turan; Esra Yazici
Journal:  Neuropsychiatr Dis Treat       Date:  2018-07-16       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.